• He showed in 2002 that feeding hamsters nontoxic bacteria was 90% effective at holding off the bad C. difficile strains.

    FORBES: Germ Warfare

  • For many banks this could be as bad as Plan C (an Argentine-style simultaneous default and devaluation), because losses on bond holdings might imperil their own solvency and further cut them off from market funding.

    ECONOMIST: European banks

  • It is the phenomenon whereby we assume that because people are good at doing A they will be good at doing B, C and D (or the reverse because they are bad at doing A they will be bad at doing B, C and D).

    ECONOMIST: Idea

  • That would be bad news for hepatitis C players such as Gilead and Bristol-Myers Squibb.

    FORBES: Battleground Vertex

  • Of course, whether it's good or bad for the A.C.

    CNN: Free Speech On The Net At The Supreme Court

  • For people concerned about their lung health, taking vitamin E and C is not a bad idea, says Blumberg.

    CNN: Vitamin E may protect lungs

  • Doctors prescribed a series of increasingly potent antibiotics to try to knock out the new bad bug, Clostridium difficile (C. diff), but nothing worked.

    CNN: Best cure for stomach troubles-- which probiotics work and why

  • Unfortunately for the rest of the professional service C corporations out there, a bad precedent has been set.

    FORBES: Seventh Circuit Surprised To See Accounting Firm "Screw Up Its Taxes"

  • "Clearly, it's telling us that these results are poor, but relative to what people were expecting, they're not so bad, " Jeffrey Lindsay, analyst at Sanford C.

    FORBES: Magazine Article

  • During the past fifteen years, the medium has been transformed by bad boys like Walter White and sad sacks like Louis C.

    NEWYORKER: Hannah Barbaric

  • More bad news: Mid-stage trials of a new drug for hepatitis C being developed by Wyeth and biotech Viropharma were stopped.

    FORBES

  • C. to brief Chief Financial Officer Doug Maine on carrier bad debt.

    FORBES: Aggressive Accounting

  • More bad news: Mid-stage trials of a new drug for hepatitis C being developed by Wyeth and biotech Viropharma (nasdaq: VPHM - news - people ) were stopped.

    FORBES: Wyeth's Worries

  • C. takes the firm into receivership, divesting it of its bad assets and returning its healthy assets to the private sector as quickly as possible.

    NEWYORKER: The Contrarian

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定